BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2784491)

  • 1. Pentostatin in chronic lymphocytic leukemia: a phase II trial of Cancer and Leukemia group B.
    Dillman RO; Mick R; McIntyre OR
    J Clin Oncol; 1989 Apr; 7(4):433-8. PubMed ID: 2784491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
    J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
    J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Smyth JF; Paine RM; Jackman AL; Harrap KR; Chassin MM; Adamson RH; Johns DG
    Cancer Chemother Pharmacol; 1980; 5(2):93-101. PubMed ID: 6970630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose deoxycoformycin in lymphoid malignancy.
    Grever MR; Leiby JM; Kraut EH; Wilson HE; Neidhart JA; Wall RL; Balcerzak SP
    J Clin Oncol; 1985 Sep; 3(9):1196-201. PubMed ID: 2993534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
    Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
    Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycin.
    Cummings FJ; Crabtree GW; Wiemann MC; Spremulli EN; Parks RE; Calabresi P
    Clin Pharmacol Ther; 1988 Nov; 44(5):501-9. PubMed ID: 3263248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentostatin in the treatment of advanced hairy cell leukemia.
    Kraut EH; Bouroncle BA; Grever MR
    J Clin Oncol; 1989 Feb; 7(2):168-72. PubMed ID: 2783731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Macdonald JS; Marsoni S; Bruno S; Poster D
    Recent Results Cancer Res; 1982; 80():323-30. PubMed ID: 6977170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment with 2'-deoxycoformycin in a case of adult T-cell leukemia].
    Ishii M; Yamaguchi K; Yul LS; Oda T; Takatsuki K
    Rinsho Ketsueki; 1986 May; 27(5):780-3. PubMed ID: 3018324
    [No Abstract]   [Full Text] [Related]  

  • 11. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
    Spiers AS; Parekh SJ
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentostatin (2'deoxycoformycin) for the treatment of lymphoid neoplasms.
    Ho AD; Thaler J; Willemze R; Lauria F; Derossi G; Kuse R; Stryckmans P; Blanc CM; Cataldo F; McVie G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():60-2. PubMed ID: 2653520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute lymphoblastic leukemia with the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Mitchell BS; Koller CA; Kelley WN
    Adv Exp Med Biol; 1979; 122B():347-50. PubMed ID: 317568
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia.
    Yamaguchi K; Yul LS; Oda T; Maeda Y; Ishii M; Fujita K; Kagiyama S; Nagai K; Suzuki H; Takatsuki K
    Leuk Res; 1986; 10(8):989-93. PubMed ID: 3489140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.
    Kefford RF; Fox RM
    Cancer Chemother Pharmacol; 1983; 10(2):73-8. PubMed ID: 6600985
    [No Abstract]   [Full Text] [Related]  

  • 17. 2'-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma.
    Lofters W; Campbell M; Gibbs WN; Cheson BD
    Cancer; 1987 Dec; 60(11):2605-8. PubMed ID: 2890428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
    Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
    Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
    Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of pentostatin (2'-deoxycoformycin, dCF) in the management of lymphoproliferative malignancies.
    Spiers AS
    Blood Rev; 1987 Jun; 1(2):106-10. PubMed ID: 3332090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.